Alice Lorusso Publishes Study on Optimized Pathogen Reduction for Double-Dose Platelets
Alice Lorusso, Senior Medical Scientist at Irish Blood Transfusion Service, posted on LinkedIn:
”Thrilled to share that my paper “Optimized pathogen reduction of double-dose platelets pooled from seven buffy coats using the TACSI system” has been published in Vox Sanguinis.
This study explores how double-dose platelet components can be safely pathogen-reduced while maintaining excellent in-vitro quality and compliance with EDQM specifications.
Grateful to my co-authors and colleagues for the teamwork and dedication that made this possible ”
Read the full article here.
Title: Optimized pathogen reduction of double-dose platelets pooled from seven buffy coats using the TACSI® system
Authors: Alice Lorusso, Liam Morgan, Aileen Farrelly, Mark Lambert, Barry Doyle, Paul Hendrick, Einas Elsheikh, Andrew Godfrey, Tor Hervig, Allison Waters
Stay updated with Hemostasis Today.
-
Nov 10, 2025, 10:16Pablo Corral on Enlicitide: The Phase 3 CORALreef HeFH Trial Brings a Major Step Forward
-
Nov 10, 2025, 10:15Laurent Bertoletti Invites You to the Joint INNOVTE and GITA Meeting on Hormones and Thrombosis
-
Nov 10, 2025, 10:15Christopher Cannon: DOAC Monotherapy Wins Again
-
Nov 10, 2025, 10:14Marieke Kruip on Sex differences in Outcomes of VKA Treatment in Patients with Mechanical Heart Valve
-
Nov 10, 2025, 10:14Ana Paula Lacombe: From Research to Bedside, Innovation in Stroke Care is Moving Fast!
-
Nov 10, 2025, 10:13Jan Sloves: Understanding Iliofemoral DVT – What You Can’t Afford to Miss
-
Nov 10, 2025, 10:12Mohamed Rawy Shares a Comprehensive Guide For Anticoagulation
-
Nov 10, 2025, 10:10Marc Carrier: Proud to Share the Results of the WAVe Study
-
Nov 10, 2025, 10:07Frederik Denorme – The New PI at the Laboratory of Cell Biology and Histology at University of Antwerp